340B Leaders Upfront is your exclusive window into the industry leaders that provide products and services to hospitals, community health centers and other 340B providers to help them implement and comply with the 340B drug pricing program. Each episode, posted monthly, provides a special opportunity to get to know the C-suite executives of 340B Report's impressive group of sponsors, the valuable expertise they provide, and their insights on key developments in this critically important drug discount program.
340B 360
Claim This Podcastby 340B Report
16 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
8
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality16
Social0
YouTube0
Engagement0
Podcast Overview
340B Leaders Upfront is your exclusive window into the industry leaders that provide products and services to hospitals, community health centers and other 340B providers to help them implement and comply with the 340B drug pricing program. Each episode, posted monthly, provides a special opportunity to get to know the C-suite executives of 340B Report's impressive group of sponsors, the valuable expertise they provide, and their insights on key developments in this critically important drug discount program.
Language
🇺🇲
Publishing Since
4/17/2025
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
8
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality16
Social0
YouTube0
Engagement0
5
Excellent Areas
2
Good Performance
12
Growth Opportunities
excellent
Episode Length
26 minutes
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
needs improvement
Publishing Consistency
Every 26 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for 340B 360
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 10, 2026
Episode 16: Reimagining 340B Business Intelligence: A Conversation with Executive Leaders at PharmaForce
<p id="docs-internal-guid-25251d0a-7fff-25e8-165c-6d4d01cf7deb" dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> In this episode of our business podcast 340B Leaders Upfront, host Anna Mangum sits down with Lynn Eschenbacher, Chief Pharmacy and Strategy Officer, and Anthony Velazquez, Chief Product Officer. PharmaForce is a pharmacy solutions provider, third-party administrator (TPA), and pharmacy benefits manager (PBM) that provides</span> <span style= "font-size: 10.5pt; font-family: Arial,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">inventory management, contract pharmacy, split billing implementation, referral capture, and 340B ESP reporting services to 340B health systems and grantees.</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Key Topics Covered:</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Formative Experiences in 340B</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Lynn and Anthony outline their career trajectories in pharmacy leadership and business operations, respectively, and formative experiences in providing pharmacy services to vulnerable patient populations in 340B settings. Lynn describes her roles with a number of prestigious academic health centers and start-up ventures. Anthony describes his 340B business and compliance roles with both health centers and health systems in the Philadelphia area.</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Information to Action to Outcomes</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Anthony provides an overview of how PharmaForce is reimagining the TPA space, anchored by an evolving business intelligence platform that enables covered entities (CEs) to help meet the new compliance requirements and other challenges in 340B. Lynn reviews several key features of the platform: adaptability, real-time transparency, data insight, and unification of siloed functions and data streams.</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Investing in Technology vs. More FTEs</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Anthony provides a historical perspective, observing that today's CEs are at an inflection point: having to deploy ever increasing numbers of highly specialized staff to operate the 340B program, and why embracing technology can play a key role in alleviating the burden. He showcases the value of PharmaForce's offerings in enabling CEs to more effectively meet the growing volume and magnitude of compliance demands.</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Supporting Clients in Addressing State-Level Action</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Lynn provides an overview of how PharmaForce supports clients in navigating the fragmented and sometimes confusing landscape of state-level contract pharmacy restrictions and provider reporting requirements, ranging from interpreting new policies to implementing documentation discipline.</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> 340B Leadership Skills</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Lynn outlines key skills in effective operational leadership for the 340B programs of today: approaching 340B strategically, versus administering 340B as an isolated program within a larger healthcare system or context; crafting the CE's narrative around 340B, to ensure that it is accurate; cultivating relationships with C-suite leaders; and investing in IT and other infrastructure solutions to more efficiently manage increasingly complex 340B operations.</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Follow our Podcasts</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Stay tuned for more episodes of 340B Leaders Upfront, which are posted monthly! Subscribe to 340B Leaders Upfront on your favorite podcast platform or YouTube.</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Bonus:</span> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Listen to Inside 340B Report, our twice-monthly podcast, to get a behind-the-scenes window into the latest 340B news and developments from the journalists at 340B Report.</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: bold; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> Special Offer for New 340B Report Subscribers</span></p> <p dir="ltr" style= "line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;"> <span style= "font-size: 10.5pt; font-family: Roboto,sans-serif; color: #131313; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> First-time subscribers to 340B Report can use code PODCAST25 for 25% off when subscribing. Or contact us for a free 15-day trial to see why 340B Report is the indispensable source for 340B news and intelligence.</span></p>
May 19, 2026
Episode 15: 340B Neutral Clearinghouse Pioneers: A Conversation with Executive Leaders at RxParadigm
<p>In this episode of our business-focused podcast 340B Leaders Upfront, host Anna Mangum sits down with RxParadigm senior leaders Tim Neylan, Chief Operating Officer and Lauren Reiss, Chief Strategy Officer. RxParadigm is a pharmacy technology solutions provider developing what the firm describes as the first ever neutral 340B claims clearinghouse. Tungsten+PLUS™ is a new system to resolve duplicate discounts and other pricing discrepancy challenges. </p> <p>A neutral infrastructure, RxParadigm argues, is particularly important because it provides a shared operational framework that is not exclusively controlled by manufacturers, covered entities (CEs), or other single stakeholders. This can support greater trust, transparency, standardization, and operational consistency.</p> <p><strong>Key Topics Covered: </strong></p> <p><strong>Pathway to 340B</strong> </p> <p>Tim and Lauren outline their backgrounds in managed IT services and business process and operations, respectively. Lauren shares how working in 340B is a "family" business for her, her brother and their children, who are following in Lauren's father's footsteps in 340B service companies.</p> <p><strong>340B Skillset</strong></p> <p>Lauren discusses some of the key skills and aptitudes that are increasingly valuable for 340B professionals: coordinating across multiple, often disconnected systems, understanding how to interpret and apply data across business functions, and adaptability.</p> <p><strong>Mitigating Medicare Maximum Fair Price Workflow Impacts</strong></p> <p>Tim provides an overview of RxParadigm's portfolio and how it continues to support clients in navigating the increasing pace of policy changes in the 340B landscape. Lauren emphasizes the need for providers to have ready access and visibility into their own data, and for standardized processes and policies to respond to the disparate types and patterns of data requests from drug manufacturers and other stakeholders. </p> <p>Lauren discusses RxParadigm's recent analysis showing that 40% of Medicare Maximum Fair Price (MFP) claims missed the mark in January, the first month of the new program's effectuation, and how the firm supports clients in improving their performance given operationally complex and heavy MFP workflows. She describes how Tungsten+PLUS™ takes care of disputes when MFP reimbursements and 340B rebate payments are not made accurately, on time, or at all.</p> <p><strong>Oregon and National 340B Claims Clearinghouse Solutions</strong></p> <p>Tim outlines how RxParadigm is serving as a clearinghouse for data from CEs and pharmacies in Oregon, in response to a new state policy requiring CEs and their pharmacies to include a 340B indicator.<br /> Tim also touches upon the Rx Paradigm's first of its kind national neutral clearinghouse. Unlike the current vendors that are retained by the drug industry to collect claims data from CEs, Rx Paradigm's service is an impartial solution to the industry-wide challenge of 340B de-duplication, enabling trusted coordination, compliance, and accuracy across stakeholders without the need to share sensitive information. </p> <p><strong>Follow our Podcasts</strong></p> <p>Stay tuned for more episodes of 340B Leaders Upfront, which are posted monthly! Subscribe to 340B Leaders Upfront on your favorite podcast platform or YouTube. </p> <p><strong>Bonus:</strong> Listen to Inside 340B Report, our twice-monthly podcast, to get a behind-the-scenes window into the latest 340B news and developments from the journalists at 340B Report.</p> <p><strong>Special Offer for New 340B Report Subscribers</strong><br /> First-time subscribers to 340B Report can use code PODCAST25 for 25% off when <a href= "https://340breport.com/subscribe/">subscribing</a>. Or contact us for a free 15-day trial to see why 340B Report is the indispensable source for 340B news and intelligence.</p>
April 17, 2026
Episode 14: 340B Voices and Value: A Conversation with Nick Rebmann, Executive VP and Chief Growth Officer of Pillr Health
<p>In this episode of our business-focused podcast 340B Leaders Upfront, host Anna Mangum sits down with Nick Rebmann, Executive Vice President and Chief Growth Officer of Pillr Health. Pillr Health is a leading provider of innovative solutions designed to optimize and streamline pharmacy operations. Their focus is on enhancing efficiency, reducing costs, and improving patient outcomes, particularly within the 340B space.</p> <p><strong>Key Topics Covered:</strong> </p> <p><strong>Pathway to 340B and Pillr Health</strong></p> <p>Nick outlines his journey to 340B, including his education as a PharmD and MBA and his stint at Rite Aid. He describes his later roles including COO at Hudson Headwaters Health Network, the renowned community health center in upstate New York, where he grew up and continues to reside, and subsequently CEO of the 340B services company Hudson Headwaters 340B, which was acquired by Pillr Health. </p> <p><strong>Skills and Mentors</strong></p> <p>Nick describes the varied skills and aptitudes that enable professionals to navigate 340B. He also discusses the mentoring he received at all levels of his career and its importance in shaping his leadership effectiveness and direction.</p> <p><strong>Value Proposition</strong></p> <p>Nick provides an overview of Pillr Health's 340B portfolio, highlighting the firm's pharmacy accelerator, which supports clients in expanding current pharmacies or building specialty pharmacies. He discusses Pillr's Rebate Readiness Center which helps clients navigate the anticipated shift of some 340B drugs from an upfront discount to a rebate model. He also touches upon its offerings aimed at alleviating contract pharmacy restrictions and manufacturer claims data requirements.</p> <p><strong>Community Voices 340B</strong></p> <p>Nick describes Community Voices 340B (CV340B), a grassroots 340B advocacy organization which he chairs and for which Pillr Health was a founding member. He describes the organization's success stories and urges providers to continue to showcase 340B's essential role in serving vulnerable patients.</p> <p><strong>Follow our Podcasts</strong></p> <p>Stay tuned for more episodes of 340B Leaders Upfront, which are posted monthly! Follow 340B Leaders Upfront on your favorite podcast platform or YouTube. </p> <p><strong>Bonus:</strong> Listen to Inside 340B Report, our twice-monthly podcast, to get a behind-the-scenes window into the latest 340B news and developments from the journalists at 340B Report.</p> <p><strong>Special Offer for New 340B Report Subscribers</strong><br /> First-time subscribers to 340B Report can use code PODCAST25 for 25% off when subscribing. Or contact us for a free 15-day trial to see why 340B Report is the indispensable source for 340B news and intelligence.</p>
16 total episodes available
Recent guests on 340B 360
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Joel Wright
Guest
John Stephens
Guest
Lidia Rodriguez-Hupp
Guest
Tara Hanuscak
Guest
Rob Ferraro
Guest
Scott Seidelmann
Guest
Brenda Barry
Guest
Ali Farzad
Guest
Alice Cheng
Guest
David Valentine
Guest
Anthony Velasquez
Guest
Joy Liu
Guest
Similar Podcasts
Discover related shows you might enjoy
Inside 340B Report
340B Report
340Banter Podcast
FQHC 340B Compliance
340B Unscripted
SpendMend Pharmacy
340B Insight
340B Health
340B Pulse
NorthArcHealth
The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.
Sykes & Company, P.A.
The Tucker Carlson Podcast
Tucker Carlson Network
Up First
NPR
Shawn Ryan Show
Shawn Ryan
The Joe Rogan Experience
Joe Rogan
Deep-dive analytics for 340B 360
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is 340B 360?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.